HKPD

Name

HKPD

Legal name

Hong Kong Pharma Distributors

Website

https://hkpd-global.com

Company type

Private

Founded year

2006

Operating status

Operating

Short description

HKPD is a Hong Kong-based pharmaceutical marketing and distribution company that sources over 1,200 Active Pharmaceutical Ingredients from top global manufacturers and distributes them through a global network of regional distributors, serving pharmaceutical companies across Latin America, the Middle East, North America, Europe, and emerging markets.

Ownership category

akta.pro rank

Product category

Pharmaceutical API Distribution

NAICS

Drugs and Druggists' Sundries Merchant Wholesalers (424210), Wholesale Trade Agents and Brokers (425)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Medicinal Chemicals & Botanical Products (2833)

akta.pro industry

PRIMARYHLAIAJAO

Compounding Ingredient & API Distributors (Pharma Supply)

Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Distribution & Wholesaling

SECONDARYHLAIABAG

Generic APIs & Intermediates (Active Ingredients)

Healthcare & Life Sciences/Pharmaceuticals/Generic Pharmaceuticals

SECONDARYHLAGAHAM

Small-Molecule CMC Documentation & Regulatory Support (DMF/CMC)

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/API & Small-Molecule Development/Manufacturing Services

Keywords

• Pharmaceutical distribution
• API sourcing
• Active pharmaceutical ingredients
• Regulatory documentation services
• Pharmaceutical marketing

Headquarters

HQ city

Hong Kong

HQ country

Hong Kong SAR China

HQ region

Asia

Offices5 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Supply Chain, Operations, Personnel, Marketing or Sales, Others

Revenue model

1. API Distribution: HKPD sources Active Pharmaceutical Ingredients from reputable global manufacturers and markets their products worldwide. Revenue is generated through the trading and distribution of APIs to pharmaceutical companies and distributors across multiple regions including Latin America, Middle East, North America, and Europe.

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels5 records

Core offering

HKPD sources Active Pharmaceutical Ingredients (APIs) from reputed top manufacturers across the globe and markets them worldwide through an extensive distributor network. The company's portfolio includes over 1,200 products covering complex therapeutic lines, complemented by APIs registration services for regulated and non-regulated markets and full supporting documentation (DMF, COPP, GMP, QA/QC). Customers request pricing via the website quote form and receive products through direct sales and regional distributors.

Product overview

HKPD (Hong Kong Pharma Distributors) is a pharmaceutical marketing and distribution company that operates as a single unified offering focused on Active Pharmaceutical Ingredients (APIs). Their portfolio includes over 1200 products sourced from top global manufacturers. The core product is the APIs catalog, supplemented by APIs Registration Services for regulated and non-regulated markets and Supporting Documentation Services that provide DMF, COPP, GMP compliance, and QA/QC documentation. The company serves pharmaceutical clients across Latin America, the Middle East, North America, and worldwide through an extensive distributor network.

Differentiator

Problem solved

Functional benefit

Products and services

• Active Pharmaceutical Ingredients (APIs) Sourced Active Pharmaceutical Ingredients from reputed top global manufacturers, marketed and distributed worldwide through an extensive distributor network. The catalog covers complex therapeutic lines and is intended for pharmaceutical manufacturers and distributors across regulated and non-regulated markets.
• APIs Registration Services Registration services for Active Pharmaceutical Ingredients in both regulated and non-regulated markets, enabling pharmaceutical companies to meet regulatory requirements across different jurisdictions.
• Supporting Documentation Services Full supporting documentation services including DMF (Drug Master File), COPP (Certificate of Pharmaceutical Product), GMP (Good Manufacturing Practice) compliance, QA/QC documentation, pharmacovigilance support, stability studies, and clinical studies of efficiency for products requiring them.

Quantifiable outcome

• Wide therapeutic coverage with over 1200 products

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

One partnership is on record.

• Top Level Industry PlayerscoreOthersHKPD works with top level industry players as shown in their 'Our partners' section featuring logos of 13 pharmaceutical industry companies. The specific names and nature of partnerships are not individually detailed in the source material.

Scale indicators4 records

Recent moves5 records

Expansion highlights4 records

Emerging players

• Laurus Labs: Laurus Labs is an Indian API and formulation manufacturer that has scaled internationally. Comparable to HKPD in emerging-market API distribution orientation, though Laurus owns manufacturing and has higher finished-dose exposure.

Direct peers

• Polpharma: Polpharma is a Polish pharmaceutical manufacturer with a significant API portfolio distributed across Europe and emerging markets. Highly comparable to HKPD in offering broad API coverage with regulatory documentation support in regulated and non-regulated markets.

Broad incumbents

• Cambrex: Cambrex is a global small-molecule API manufacturer and CDMO offering development, scale-up, and commercial supply. Comparable to HKPD in serving pharma customers with documented APIs across therapeutic categories, but Cambrex owns its plants and competes upstream.
• Siegfried Holding: Siegfried is a Swiss-based API manufacturer with global commercial API distribution. Comparable to HKPD in supplying documented, GMP-compliant APIs to pharma customers worldwide, though it adds its own manufacturing footprint.
• Hovione: Hovione is a CDMO and API manufacturer with strong regulatory documentation and global pharma customers. Comparable to HKPD in the regulatory intensity and therapeutic breadth of its API offering, though it is principally a contract manufacturer.
• Teva Active Pharmaceutical Ingredients (TAPI): TAPI is one of the world's largest API manufacturers and distributors, offering a broad portfolio across therapeutic categories. Comparable to HKPD because it supplies documented APIs (DMF, GMP) to global pharma customers, although at vastly larger scale and with its own manufacturing.
• Divis Laboratories: Divis is a large Indian API manufacturer with significant generic API and intermediate exports. Comparable to HKPD in supplying APIs globally with regulatory documentation, but at a much larger scale and with owned manufacturing.
• Aurobindo Pharma: A vertically integrated Indian pharma company with a large API manufacturing base and global distribution. Comparable to HKPD in API product breadth and emerging-market reach, but Aurobindo owns its manufacturing and serves as both supplier and competitor.
• Dr. Reddy's Laboratories (API Division): Dr. Reddy's operates a substantial API business supplying documented active ingredients globally. Comparable to HKPD in targeting regulated and semi-regulated markets with DMF-backed APIs, though it is also a finished-dose manufacturer with much broader scale.
• Seqens (formerly PCAS): Seqens is a French-headquartered specialty API manufacturer and distributor serving global pharma. Comparable to HKPD in providing documented APIs across therapeutic categories, though it owns manufacturing assets.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about HKPD